Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancrea

• 作 者: Se Jun Park Hyunho Kim Kabsoo
• 机 构: DivisionofMedicalOncology,DepartmentofGeneralSurgery
• 出 处: 世界胃肠肿瘤学杂志:英文版(电子版)
• 发表日期: 2019年11期
• 关键词: PANCREATIC cancer Gemcitabine-refractory CAPECITABINE S-1 SECOND-LINE treatment

BACKGROUND There is no standard therapy for second-line treatment of gemcitabine-refractory pancreatic cancer patients with poor performance status.A combination of chemotherapy drugs 5-fluorouracil(5-FU),leucovorin,irinotecan,and oxaliplatin(FOLFIRINOX)o